GALA RENEE D 4

What Happened Renee D. Gala, President & CEO of Jazz Pharmaceuticals plc (JAZZ), reported a gift (code G) of 600 ordinary shares on June 3, 2026. The Form 4 lists the transaction price as $0.00 and total value as $0 because the shares were donated rather than sold. This was a gift/disposition, not a purchase — gifts typically do not signal the insider’s view of the company’s prospects.

Key Details

• Transaction date: 2026-06-03; Reported on Form 4: 2026-06-05 (timely filing within the standard 2-business-day window).
• Transaction type: Gift (code G); 600 shares disposed; price shown $0.00; total reported value $0.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes: F1 — Shares were donated to The Gala Family Fund, a donor‑advised fund. F2 — The reporting person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026 (separate acquisition disclosed).
• No indication of a 10b5-1 plan or cashless exercise in this filing.

Context Gifts to donor‑advised funds are common for charitable and tax‑planning reasons and do not necessarily reflect the insider’s sentiment about the stock. The separate ESPP purchase (166 shares) noted in the filing is a routine employee plan acquisition and is more directly a purchase signal than the gift transaction.